Greg Garfield - Semler Scientific Director
| SMLR Stock | USD 27.00 0.48 1.81% |
Director
Mr. Greg S. Garfield is Director of the Semler Scientific Inc . since November 2013. Mr. Garfield serves as a director on the boards of seven private companies in the healthcare industry. From 2006 to 2011 he had various roles at Acclarent Inc. a medical technology company including Chief Operating Officer and General Counsel. Acclarent Inc. was acquired by Johnson and Johnson at a valuation of approximately 800 million cash in January 2010. From 1995 to 2006 Mr. Garfield had various roles at Guidant Corporation a medical technology company including Vice President of Business Development and General Counsel. Guidant was acquired by Boston Scientific Corporation in 2006 at a valuation of approximately 27 billion in cash and stock since 2013.
| Age | 52 |
| Tenure | 11 years |
| Address | 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051 |
| Phone | (877) 774-4211 |
| Web | https://www.semlerscientific.com |
Semler Scientific Management Efficiency
The company has return on total asset (ROA) of 0.2042 % which means that it generated a profit of $0.2042 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3229 %, meaning that it created $0.3229 on every $100 dollars invested by stockholders. Semler Scientific's management efficiency ratios could be used to measure how well Semler Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Semler Scientific's Return On Tangible Assets are relatively stable compared to the past year. As of 05/04/2024, Return On Assets is likely to grow to 0.28, while Return On Capital Employed is likely to drop 0.29. At this time, Semler Scientific's Intangibles To Total Assets are relatively stable compared to the past year. As of 05/04/2024, Fixed Asset Turnover is likely to grow to 23.82, while Other Assets are likely to drop 0.95.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Donald Berwick | National Research Corp | 71 | |
| Michael Shmerling | HealthStream | 62 | |
| Thompson Dent | HealthStream | 68 | |
| Barbara Mowry | National Research Corp | 70 | |
| John Nunnelly | National Research Corp | 65 | |
| Martiny Harris | HealthStream | 59 | |
| Frank Gordon | HealthStream | 55 | |
| Harald Arnet | National Research Corp | N/A | |
| Brita Eilertsen | National Research Corp | 53 | |
| Linda Rebrovick | HealthStream | 62 | |
| P Shastri | National Research Corp | 65 | |
| William Stead | HealthStream | 69 | |
| JoAnn Martin | National Research Corp | 63 | |
| Dale Polley | HealthStream | 67 | |
| Kjersti Kanne | National Research Corp | N/A | |
| Deborah Tate | HealthStream | 61 | |
| Savita Acharya | National Research Corp | 41 | |
| Martin Harris | HealthStream | 61 | |
| Jeffrey McLaren | HealthStream | 51 | |
Management Performance
Semler Scientific Leadership Team
Elected by the shareholders, the Semler Scientific's board of directors comprises two types of representatives: Semler Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Semler. The board's role is to monitor Semler Scientific's management team and ensure that shareholders' interests are well served. Semler Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Semler Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dennis Rosenberg, Chief Officer | ||
| Aidan Collins, Director | ||
| Arthur Leibowitz, Director | ||
| Chutorian Murphy, CEO, Director | ||
| Herbert Semler, Chairman of the Board, Co-Founder | ||
| Andrew Weinstein, Principal Financial Officer, Senior Vice President - Finance and Accounting | ||
| James Walker, CFO | ||
| Douglas MD, President CEO | ||
| Cindy Guinasso, Senior Development | ||
| Robert McRae, Chief Officer | ||
| Bruce Barclay, Director | ||
| Jennifer Herrington, Chief Officer | ||
| Shirley Semler, Co-Founder, Director | ||
| Douglas MurphyChutorian, President CEO, Director | ||
| Shane Reid, Chief Officer | ||
| Wayne Pan, Director | ||
| Greg Garfield, Director | ||
| Daniel Conger, VP of Fin. | ||
| Renae Cormier, Principal CFO |
Semler Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Semler Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.2 | ||||
| Profit Margin | 0.30 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 132.8 M | ||||
| Shares Outstanding | 7.03 M | ||||
| Shares Owned By Insiders | 22.22 % | ||||
| Shares Owned By Institutions | 52.39 % | ||||
| Number Of Shares Shorted | 247.26 K | ||||
| Price To Earning | 16.64 X |
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Semler Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Semler Stock, please use our How to Invest in Semler Scientific guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Semler Stock analysis
When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Semler Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Semler Scientific. If investors know Semler will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Semler Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.315 | Earnings Share 2.63 | Revenue Per Share 10.127 | Quarterly Revenue Growth 0.091 | Return On Assets 0.2042 |
The market value of Semler Scientific is measured differently than its book value, which is the value of Semler that is recorded on the company's balance sheet. Investors also form their own opinion of Semler Scientific's value that differs from its market value or its book value, called intrinsic value, which is Semler Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Semler Scientific's market value can be influenced by many factors that don't directly affect Semler Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Semler Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Semler Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Semler Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.